|
1
|
Zhu LF, Hu Y, Yang CC, Xu XH, Ning TY,
Wang ZL, Ye JH and Liu LK: Snail overexpression induces an
epithelial to mesenchymal transition and cancer stem cell-like
properties in SCC9 cells. Lab Invest. 92:744–752. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun L, Diamond ME, Ottaviano AJ, Joseph
MJ, Ananthanarayan V and Munshi HG: Transforming growth factor-beta
1 promotes matrix metalloproteinase-9-mediated oral cancer invasion
through snail expression. Mol Cancer Res. 6:10–20. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Silverman S Jr: Demographics and
occurrence of oral and pharyngeal cancers. The outcomes, the
trends, the challenge. J Am Dent Assoc. 132(Suppl): S7–S11. 2001.
View Article : Google Scholar
|
|
4
|
Ramos DM, Dang D and Sadler S: The role of
the integrin alpha v beta6 in regulating the epithelial to
mesenchymal transition in oral cancer. Anticancer Res. 29:125–130.
2009.PubMed/NCBI
|
|
5
|
Crnic I and Christofori G: Novel
technologies and recent advances in metastasis research. Int J Dev
Biol. 48:573–581. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Molloy T and van ’t Veer LJ: Recent
advances in metastasis research. Curr Opin Genet Dev. 18:35–41.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang CC, Zhu LF, Xu XH, Ning TY, Ye JH and
Liu LK: Membrane Type 1 matrix metalloproteinase induces an
epithelial to mesenchymal transition and cancer stem cell-like
properties in SCC9 cells. BMC Cancer. 13:1712013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Medema JP: Cancer stem cells: The
challenges ahead. Nat Cell Biol. 15:338–344. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Charafe-Jauffret E, Ginestier C, Iovino F,
Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci
F, Jacquemier J, et al: Aldehyde dehydrogenase 1-positive cancer
stem cells mediate metastasis and poor clinical outcome in
inflammatory breast cancer. Clin Cancer Res. 16:45–55. 2010.
View Article : Google Scholar
|
|
11
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar
|
|
12
|
Fan YL, Zheng M, Tang YL and Liang XH: A
new perspective of vasculogenic mimicry: EMT and cancer stem cells
(Review). Oncol Lett. 6:1174–1180. 2013.PubMed/NCBI
|
|
13
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Elsaba TM, Martinez-Pomares L, Robins AR,
Crook S, Seth R, Jackson D, McCart A, Silver AR, Tomlinson IP and
Ilyas M: The stem cell marker CD133 associates with enhanced colony
formation and cell motility in colorectal cancer. PLoS One.
5:e107142010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bapat SA, Mali AM, Koppikar CB and Kurrey
NK: Stem and progenitor-like cells contribute to the aggressive
behavior of human epithelial ovarian cancer. Cancer Res.
65:3025–3029. 2005.PubMed/NCBI
|
|
16
|
Hemmati HD, Nakano I, Lazareff JA,
Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI:
Cancerous stem cells can arise from pediatric brain tumors. Proc
Natl Acad Sci USA. 100:15178–15183. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
18
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang D, Nguyen TK, Leishear K, Finko R,
Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE and Herlyn M: A
tumorigenic subpopulation with stem cell properties in melanomas.
Cancer Res. 65:9328–9337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Monroe MM, Anderson EC, Clayburgh DR and
Wong MH: Cancer stem cells in head and neck squamous cell
carcinoma. J Oncol. 2011:7627802011. View Article : Google Scholar
|
|
22
|
Davis SJ, Divi V, Owen JH, Bradford CR,
Carey TE, Papagerakis S and Prince ME: Metastatic potential of
cancer stem cells in head and neck squamous cell carcinoma. Arch
Otolaryngol Head Neck Surg. 136:1260–1266. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang CC, Hsu WH, Wang CC, Chou CH, Kuo
MY, Lin BR, Chen ST, Tai SK, Kuo ML and Yang MH: Connective tissue
growth factor activates pluripotency genes and
mesenchymal-epithelial transition in head and neck cancer cells.
Cancer Res. 73:4147–4157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nguyen PT, Kudo Y, Yoshida M, Iizuka S,
Ogawa I and Takata T: N-cadherin expression is correlated with
metastasis of spindle cell carcinoma of head and neck region. J
Oral Pathol Med. 40:77–82. 2011. View Article : Google Scholar
|
|
25
|
Mizrak D, Brittan M and Alison M: CD133:
Molecule of the moment. J Pathol. 214:3–9. 2008. View Article : Google Scholar
|
|
26
|
Neuzil J, Stantic M, Zobalova R, Chladova
J, Wang X, Prochazka L, Dong L, Andera L and Ralph SJ:
Tumour-initiating cells vs. cancer ‘stem’ cells and CD133: What’s
in the name? Biochem Biophys Res Commun. 355:855–859. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Olempska M, Eisenach PA, Ammerpohl O,
Ungefroren H, Fandrich F and Kalthoff H: Detection of tumor stem
cell markers in pancreatic carcinoma cell lines. Hepatobiliary
Pancreat Dis Int. 6:92–97. 2007.PubMed/NCBI
|
|
28
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
29
|
Lim W, Kim J, Kim S, Karna S, Won J, Jeon
SM, Kim SY, Choi Y, Choi H and Kim O: Modulation of
lipopolysaccharide-induced NF-κB signaling pathway by 635 nm
irradiation via heat shock protein 27 in human gingival fibroblast
cells. Photochem Photobiol. 89:199–207. 2013. View Article : Google Scholar
|
|
30
|
Carvalho AL, Nishimoto IN, Califano JA and
Kowalski LP: Trends in incidence and prognosis for head and neck
cancer in the United States: A site-specific analysis of the SEER
database. Int J Cancer. 114:806–816. 2005. View Article : Google Scholar
|
|
31
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Al Saleh S, Sharaf LH and Luqmani YA:
Signalling pathways involved in endocrine resistance in breast
cancer and associations with epithelial to mesenchymal transition
(Review). Int J Oncol. 38:1197–1217. 2011.PubMed/NCBI
|
|
34
|
Pang LY, Bergkvist GT, Cervantes-Arias A,
Yool DA, Muirhead R and Argyle DJ: Identification of tumour
initiating cells in feline head and neck squamous cell carcinoma
and evidence for gefitinib induced epithelial to mesenchymal
transition. Vet J. 193:46–52. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou BB, Zhang H, Damelin M, Geles KG,
Grindley JC and Dirks PB: Tumour-initiating cells: Challenges and
opportunities for anticancer drug discovery. Nat Rev Drug Discov.
8:806–823. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Uchida N, Buck DW, He D, Reitsma MJ, Masek
M, Phan TV, Tsukamoto AS, Gage FH and Weissman IL: Direct isolation
of human central nervous system stem cells. Proc Natl Acad Sci USA.
97:14720–14725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Iannolo G, Conticello C, Memeo L and De
Maria R: Apoptosis in normal and cancer stem cells. Crit Rev Oncol
Hematol. 66:42–51. 2008. View Article : Google Scholar
|
|
38
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang X, Yao Y, Zhu J, Jin K, Wang Y, Mao Y
and Zhou L: Differential proliferative index of cancer stem-like
cells in primary and recurrent medulloblastoma in human. Childs
Nerv Syst. 28:1869–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Anjomshoaa A, Nasri S, Humar B, McCall JL,
Chatterjee A, Yoon HS, McNoe L, Black MA and Reeve AE: Slow
proliferation as a biological feature of colorectal cancer
metastasis. Br J Cancer. 101:822–828. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bourguignon LY, Wong G, Earle C and Chen
L: Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes
miR-302 expression leading to self-renewal, clonal formation, and
cisplatin resistance in cancer stem cells from head and neck
squamous cell carcinoma. J Biol Chem. 287:32800–32824. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gangopadhyay S, Nandy A, Hor P and
Mukhopadhyay A: Breast cancer stem cells: A novel therapeutic
target. Clin Breast Cancer. 13:7–15. 2013. View Article : Google Scholar
|
|
43
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bar EE, Chaudhry A, Lin A, Fan X, Schreck
K, Matsui W, Piccirillo S, Vescovi AL, DiMeco F, Olivi A, et al:
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like
cancer cells in glioblastoma. Stem Cells. 25:2524–2533. 2007.
View Article : Google Scholar : PubMed/NCBI
|
